A miR-124-3p/PKC-δ Regulatory Axis Restrains Bladder Cancer Growth and Malignant Progression
In Vivo · 2026-07 · 40 (4) · 1992-2002
DOI: 10.21873/invivo.14352 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, online erschienen am 30.06.2026. Verfasst von Yu-Cheng Kuo und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan, R.O.C. Hauptthemen laut MEDLINE: MicroRNAs, Protein Kinase C-delta, Urinary Bladder Neoplasms, Gene Expression Regulation, Neoplastic. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND/AIM: Bladder cancer is characterized by high rates of recurrence and metastasis, underscoring the need for novel molecular targets. Protein kinase C delta (PKC-δ) has been implicated in tumor progression, yet its regulatory mechanisms in bladder cancer remain unclear. MicroRNAs (miRNAs) function as crucial post-transcriptional regulators, and miR-124-3p is recognized as a potent tumor suppressor that inhibits oncogenic signaling across various malignancies. However, its specific interaction with PKC-δ in bladder cancer has not been established. This study aimed to investigate the regulatory role of the miR-124-3p/PKC-δ axis in modulating the malignant phenotypes of bladder cancer cells. MATERIALS AND METHODS: Human bladder cancer cell lines TSGH8301 and T24 were treated with the PKC inhibitor rottlerin or transfected with miR-124-3p mimic. Cell viability, proliferation, migration, invasion, epithelial-mesenchymal transition (EMT), and stemness were evaluated using cytotoxicity assays, Transwell assays, sphere formation assays, flow cytometry, and western blotting. RESULTS: Rottlerin suppressed bladder cancer cell proliferation and upregulated miR-124-3p expression. Overexpression of miR-124-3p reduced PKC-δ expression and phosphorylation, inhibited migration, invasion, EMT, and stemness, and phenocopied the effects of PKC inhibition. CONCLUSION: miR-124-3p negatively regulates PKC-δ signaling in bladder cancer cells, forming a novel miR-124-3p/PKC-δ axis that suppresses bladder cancer progression and may offer therapeutic value.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan, R.O.C.
- Department of Radiation Oncology, China Medical University Hsinchu Hospital, Hsinchu, Taiwan, R.O.C.
- Department of Radiation Oncology, Chang Bing Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C.
- Department of Dentistry, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C.
- Department of Life Sciences, National Central University, Taoyuan, Taiwan, R.O.C.
- Department of Biological Sciences, Columbia University, New York, NY, U.S.A.
Zitieren
APA
Kuo, Y. C., Wang, H. Y., Liao, T. L., Weng, Y. S., Ko, Y. C., Su, L. T., & Hsu, K. W. (2026). A miR-124-3p/PKC-δ Regulatory Axis Restrains Bladder Cancer Growth and Malignant Progression. In Vivo, 40(4), 1992-2002. https://doi.org/10.21873/invivo.14352
Vancouver
Kuo YC, Wang HY, Liao TL, Weng YS, Ko YC, Su LT, et al. A miR-124-3p/PKC-δ Regulatory Axis Restrains Bladder Cancer Growth and Malignant Progression. In Vivo. 2026;40(4):1992-2002. doi:10.21873/invivo.14352
BibTeX
@article{Kuo2026,
author = {Kuo, Yu-Cheng and Wang, Hsiao-Yu and Liao, Tsai-Lan and Weng, Yueh-Shan and Ko, Yu-Cheng and Su, Li-Ting and Hsu, Kai-Wen},
title = {A miR-124-3p/PKC-δ Regulatory Axis Restrains Bladder Cancer Growth and Malignant Progression},
journal = {In Vivo},
year = {2026},
volume = {40},
number = {4},
pages = {1992--2002},
doi = {10.21873/invivo.14352}
}
EUVIMED